UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus

Seminars in arthritis and rheumatism, 2012-08, Vol.42 (1), p.56-65

2012

Volltextzugriff (PDF)

Accuracy of a GFR Estimating Equation Over Time in People With a Wide Range of Kidney Function

American journal of kidney diseases, 2012-08, Vol.60 (2), p.217-224

2012

Volltextzugriff (PDF)

Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience

American journal of kidney diseases, 2008-05, Vol.51 (5), p.804-810

2008

Volltextzugriff (PDF)

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial : Clinical implications and limitations

Journal of the American Society of Nephrology, 2005-10, Vol.16 (10), p.3027-3037

2005

Volltextzugriff (PDF)

LupusQoL-US benchmarks for US patients with systemic lupus erythematosus

Journal of rheumatology, 2010-09, Vol.37 (9), p.1828

2010

Volltextzugriff (PDF)

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

The New England journal of medicine, 2012-07, Vol.367 (1), p.20-29

2012

Volltextzugriff (PDF)

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA

Nephrology, dialysis, transplantation, 2008-04, Vol.23 (4), p.1216-1223

2008

Volltextzugriff (PDF)

Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis

American journal of kidney diseases, 2014-07, Vol.64 (1), p.74-85

2014

Volltextzugriff (PDF)

Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration

Blood purification, 2011-01, Vol.32 (4), p.266-270

2011

Volltextzugriff (PDF)

The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics

Nephrology, dialysis, transplantation, 2000-04, Vol.15 (4), p.487-497

2000

Volltextzugriff (PDF)

An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings

Nephrology, dialysis, transplantation, 2003-10, Vol.18 (10), p.2059-2066

2003

Volltextzugriff (PDF)

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy

Clinical therapeutics, 2003-07, Vol.25 (7), p.2102-2119

2003

Volltextzugriff (PDF)

A clinical trial in type 2 diabetic nephropathy

American journal of kidney diseases, 2001-10, Vol.38 (4), p.S191-S194

2001

Volltextzugriff (PDF)

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

Nephrology, dialysis, transplantation, 2008-06, Vol.23 (6), p.1946-1954

2008

Volltextzugriff (PDF)

Renal pathology patterns in type II diabetes mellitus : relationship with retinopathy

Nephrology, dialysis, transplantation, 1998-10, Vol.13 (10), p.2547-2552

1998

Volltextzugriff (PDF)

Rapid Reversal of Bone Scan Abnormalities in a Patient With Type 1 Primary Hyperoxaluria and Oxalosis

Clinical nuclear medicine, 1994-09, Vol.19 (9), p.769-772

1994

Volltextzugriff (PDF)

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy

American journal of kidney diseases, 1995, Vol.26 (6), p.904-909

1995

Volltextzugriff (PDF)

Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy

Kidney international, 1998-07, Vol.54 (1), p.193-202

1998

Volltextzugriff (PDF)

Blood Pressures in Hemodialysis and Peritoneal Dialysis Using Ambulatory Blood Pressure Monitoring

American journal of kidney diseases, 1994-03, Vol.23 (3), p.401-411

1994

Volltextzugriff (PDF)

An 18-year-old man with Goodpasture's syndrome and ANCA-negative central nervous system vasculitis

American journal of kidney diseases, 1998-02, Vol.31 (2), p.345-349

1998

Volltextzugriff (PDF)

Cost-effectiveness of Early Irbesartan treatment versus control (standard antihypertensive medications excluding ACE inhibitors, other angiotensin-2 receptor antagonists, and dihyropyridine calcium channel blockers) or late Irbesartan treatment in patients type 2 diabetes, hypertension, and renal disease

Diabetes care, 2004, Vol.27 (8), p.1897-1903

2004

Volltextzugriff (PDF)

Reproducibility of studies of peritoneal dialysis adequacy

Kidney international, 1996-07, Vol.50 (1), p.267-271

1996

Volltextzugriff (PDF)

Re-evaluation of solute transport groups using the peritoneal equilibration test

Peritoneal dialysis international, 1999-09, Vol.19 (5), p.438-441

1999

Volltextzugriff (PDF)

Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome

Metabolism, clinical and experimental, 1994-09, Vol.43 (9), p.1126-1133

1994

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(36)

Sprache

Englisch
(36)
Japanisch
(7)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus

Accuracy of a GFR Estimating Equation Over Time in People With a Wide Range of Kidney Function

Accelerated Venovenous Hemofiltration: Early Technical and Clinical Experience

Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial : Clinical implications and limitations

LupusQoL-US benchmarks for US patients with systemic lupus erythematosus

Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C

A health economic analysis of screening and optimal treatment of nephropathy in patients with type 2 diabetes and hypertension in the USA

Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysis

Effects of High Blood Flow and High Pre-Dilution Replacement Fluid Rates on Small Solute Clearances in Hemofiltration

The Irbesartan Type II Diabetic Nephropathy Trial: study design and baseline patient characteristics

An economic evaluation of irbesartan in the treatment of patients with type 2 diabetes, hypertension and nephropathy: cost-effectiveness of Irbesartan in Diabetic Nephropathy Trial (IDNT) in the Belgian and French settings

The cost-effectiveness of irbesartan in the treatment of hypertensive patients with type 2 diabetic nephropathy

A clinical trial in type 2 diabetic nephropathy

Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria

Renal pathology patterns in type II diabetes mellitus : relationship with retinopathy

Rapid Reversal of Bone Scan Abnormalities in a Patient With Type 1 Primary Hyperoxaluria and Oxalosis

The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type 1 diabetic patients with nephropathy

Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy

Blood Pressures in Hemodialysis and Peritoneal Dialysis Using Ambulatory Blood Pressure Monitoring

An 18-year-old man with Goodpasture's syndrome and ANCA-negative central nervous system vasculitis

Role of pathology indices in the management of severe lupus glomerulonephritis

Reproducibility of studies of peritoneal dialysis adequacy

Re-evaluation of solute transport groups using the peritoneal equilibration test

Abnormal acyltransferase activities and accelerated cholesteryl ester transfer in patients with nephrotic syndrome

Aktive Filter

Suchergebnisse filtern